Study Overview
Clear description of purpose, duration, and what participation involves, written in plain language for participant comprehension.
A complete, compliant consent form reduces regulatory risk, protects participant rights, and provides clear documentation of consent for research oversight and audits. It also clarifies data-sharing parameters, supports IRB review, and demonstrates adherence to HIPAA and federal e-signature standards.
Roles vary by study and site; document signatory authority should be confirmed before execution to ensure validity.
| Setting | Recommended Value |
|---|---|
| Authentication | Email + SMS or KBA for higher risk |
| Audit Trail | Enable timestamps, IP, and signer metadata |
| Retention | Automate export to secure archive after signing |
| Access Control | Role-based permissions for study staff |
Ensure the platform can support HIPAA BAAs and maintain auditable copies for compliance and IRB review.
Date participant signs; governs start of permissions
Record consent form version and IRB approval date
Follow protocol-specific enrollment windows
Specify duration of data retention and access
Signed copies accessible during monitoring
| signNow | DocuSign | Adobe Sign | PandaDoc | HelloSign | |
|---|---|---|---|---|---|
| Starting Price | $8/user/mo | $15/user/mo | $14/user/mo | $19/user/mo | $15/user/mo |
| Free Trial | 7-day free trial, no card | No | No | Yes, limited | Yes, limited |
| Bulk Send | Yes | Yes | Yes | Yes | No |
| Audit Trail | Yes | Yes | Yes | Yes | Yes |
| HIPAA Compliant | Yes | Yes | Yes | No | No |
| Envelope Cap | No cap | 100 envelopes/user/year | Varies by plan | Varies by plan | Varies by plan |
Optica conducted a remote device usability study using an eConsent process approved by its IRB
A clinical network deployed an eSignature workflow for device evaluation across clinics
Clear description of purpose, duration, and what participation involves, written in plain language for participant comprehension.
Concise listing of foreseeable risks and potential benefits, including device-specific safety considerations and expected outcomes.
Explicit permissions for collection, storage, secondary use, and third-party disclosures, with HIPAA authorization where applicable.
Statement that participation is voluntary and withdrawal will not affect standard care, with instructions for withdrawing consent.
Signature block for participant or legally authorized representative, plus date, printed name, and contact information.
Provide study team and IRB contact details for questions, complaints, and participant rights inquiries.